CLINICAL_TRIALS ClinicalTrials.gov record update

Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03420963
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:10.194398+00:00
Published At: 2026-03-20T00:00:00+00:00
Record Updated At: 2026-03-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Recurrent Cutaneous Melanoma", "Recurrent Lip and Oral Cavity Carcinoma", "Recurrent Malignant Endocrine Neoplasm", "Recurrent Malignant Female Reproductive System Neoplasm", "Recurrent Malignant Male Reproductive System Neoplasm", "Recurrent Malignant Mesothelioma", "Recurrent Malignant Neoplasm of Multiple Primary Sites", "Recurrent Malignant Oral Neoplasm", "Recurrent Malignant Pharyngeal Neoplasm", "Recurrent Malignant Skin Neoplasm", "Recurrent Malignant Soft Tissue Neoplasm", "Recurrent Malignant Solid Neoplasm", "Recurrent Malignant Thyroid Gland Neoplasm", "Recurrent Malignant Urinary System Neoplasm", "Refractory Cutaneous Melanoma", "Refractory Malignant Bone Neoplasm", "Refractory Malignant Endocrine Neoplasm", "Refractory Malignant Female Reproductive System Neoplasm", "Refractory Malignant Male Reproductive System Neoplasm", "Refractory Malignant Mesothelioma", "Refractory Malignant Neoplasm of Multiple Primary Sites", "Refractory Malignant Oral Neoplasm", "Refractory Malignant Pharyngeal Neoplasm", "Refractory Malignant Skin Neoplasm", "Refractory Malignant Soft Tissue Neoplasm", "Refractory Malignant Solid Neoplasm", "Refractory Malignant Thyroid Gland Neoplasm", "Refractory Malignant Urinary System Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-03-20"
protocolSection.identificationModule.nctId: "NCT03420963"
protocolSection.identificationModule.officialTitle: "Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Study condition terms

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.